Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment

Julie Wagner, John Tsimikas, Gina Abbott, Mary de Groot, Alicia Heapy

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Aims: Depression is common in diabetes, but little is known about depression in minorities with diabetes. This study investigated (1) racial/ethnic variation in depressive symptoms, (2) racial/ethnic variation in patient-reported physician-diagnosed depression, (3) racial/ethnic variation in patient-reported pharmacological depression treatment, and (4) the effects of demographic and diabetes variables on these outcomes. Participants: A community sample of 740 persons with diabetes attending diabetes health fairs in the northeastern US participated. Design: Cross-sectional, observational. Participants were paid $5 on-site for completing a one-time, anonymous self-report questionnaire. Measurements: The questionnaire asked about demographics and diabetes, as well as physician-diagnosed depression and medication for depression. The Center for Epidemiological Studies Depression scale was used to determine depressive symptoms. Results: ANCOVA revealed that rates of depressive symptoms were similar among White, African-American, and Latino persons with diabetes. One quarter (24.2%) endorsed physician-diagnosed depression, and 40.2% of them (9.7% of the total sample) reported pharmacological treatment. In logistic regression, African-Americans reported lower rates of physician-diagnosed depression than Whites, OR = 0.470. In logistic regression, those African Americans who endorsed depression diagnosis reported marginally lower rates of pharmacotherapy than Whites, OR = 0.415. Conclusions: Providers are encouraged to address depression in their diabetic patients, paying particular attention to minorities.

Original languageEnglish (US)
Pages (from-to)119-122
Number of pages4
JournalDiabetes Research and Clinical Practice
Volume75
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Depression
Therapeutics
African Americans
Physicians
Logistic Models
Health Fairs
Demography
Pharmacology
Hispanic Americans
Self Report
Epidemiologic Studies
Drug Therapy

Keywords

  • Depression
  • Diabetes
  • Disparities
  • Ethnicity
  • Race

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment. / Wagner, Julie; Tsimikas, John; Abbott, Gina; de Groot, Mary; Heapy, Alicia.

In: Diabetes Research and Clinical Practice, Vol. 75, No. 1, 01.2007, p. 119-122.

Research output: Contribution to journalArticle

Wagner, Julie ; Tsimikas, John ; Abbott, Gina ; de Groot, Mary ; Heapy, Alicia. / Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment. In: Diabetes Research and Clinical Practice. 2007 ; Vol. 75, No. 1. pp. 119-122.
@article{1eca0a55d9064e12a841113b74003c67,
title = "Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment",
abstract = "Aims: Depression is common in diabetes, but little is known about depression in minorities with diabetes. This study investigated (1) racial/ethnic variation in depressive symptoms, (2) racial/ethnic variation in patient-reported physician-diagnosed depression, (3) racial/ethnic variation in patient-reported pharmacological depression treatment, and (4) the effects of demographic and diabetes variables on these outcomes. Participants: A community sample of 740 persons with diabetes attending diabetes health fairs in the northeastern US participated. Design: Cross-sectional, observational. Participants were paid $5 on-site for completing a one-time, anonymous self-report questionnaire. Measurements: The questionnaire asked about demographics and diabetes, as well as physician-diagnosed depression and medication for depression. The Center for Epidemiological Studies Depression scale was used to determine depressive symptoms. Results: ANCOVA revealed that rates of depressive symptoms were similar among White, African-American, and Latino persons with diabetes. One quarter (24.2{\%}) endorsed physician-diagnosed depression, and 40.2{\%} of them (9.7{\%} of the total sample) reported pharmacological treatment. In logistic regression, African-Americans reported lower rates of physician-diagnosed depression than Whites, OR = 0.470. In logistic regression, those African Americans who endorsed depression diagnosis reported marginally lower rates of pharmacotherapy than Whites, OR = 0.415. Conclusions: Providers are encouraged to address depression in their diabetic patients, paying particular attention to minorities.",
keywords = "Depression, Diabetes, Disparities, Ethnicity, Race",
author = "Julie Wagner and John Tsimikas and Gina Abbott and {de Groot}, Mary and Alicia Heapy",
year = "2007",
month = "1",
doi = "10.1016/j.diabres.2006.05.004",
language = "English (US)",
volume = "75",
pages = "119--122",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment

AU - Wagner, Julie

AU - Tsimikas, John

AU - Abbott, Gina

AU - de Groot, Mary

AU - Heapy, Alicia

PY - 2007/1

Y1 - 2007/1

N2 - Aims: Depression is common in diabetes, but little is known about depression in minorities with diabetes. This study investigated (1) racial/ethnic variation in depressive symptoms, (2) racial/ethnic variation in patient-reported physician-diagnosed depression, (3) racial/ethnic variation in patient-reported pharmacological depression treatment, and (4) the effects of demographic and diabetes variables on these outcomes. Participants: A community sample of 740 persons with diabetes attending diabetes health fairs in the northeastern US participated. Design: Cross-sectional, observational. Participants were paid $5 on-site for completing a one-time, anonymous self-report questionnaire. Measurements: The questionnaire asked about demographics and diabetes, as well as physician-diagnosed depression and medication for depression. The Center for Epidemiological Studies Depression scale was used to determine depressive symptoms. Results: ANCOVA revealed that rates of depressive symptoms were similar among White, African-American, and Latino persons with diabetes. One quarter (24.2%) endorsed physician-diagnosed depression, and 40.2% of them (9.7% of the total sample) reported pharmacological treatment. In logistic regression, African-Americans reported lower rates of physician-diagnosed depression than Whites, OR = 0.470. In logistic regression, those African Americans who endorsed depression diagnosis reported marginally lower rates of pharmacotherapy than Whites, OR = 0.415. Conclusions: Providers are encouraged to address depression in their diabetic patients, paying particular attention to minorities.

AB - Aims: Depression is common in diabetes, but little is known about depression in minorities with diabetes. This study investigated (1) racial/ethnic variation in depressive symptoms, (2) racial/ethnic variation in patient-reported physician-diagnosed depression, (3) racial/ethnic variation in patient-reported pharmacological depression treatment, and (4) the effects of demographic and diabetes variables on these outcomes. Participants: A community sample of 740 persons with diabetes attending diabetes health fairs in the northeastern US participated. Design: Cross-sectional, observational. Participants were paid $5 on-site for completing a one-time, anonymous self-report questionnaire. Measurements: The questionnaire asked about demographics and diabetes, as well as physician-diagnosed depression and medication for depression. The Center for Epidemiological Studies Depression scale was used to determine depressive symptoms. Results: ANCOVA revealed that rates of depressive symptoms were similar among White, African-American, and Latino persons with diabetes. One quarter (24.2%) endorsed physician-diagnosed depression, and 40.2% of them (9.7% of the total sample) reported pharmacological treatment. In logistic regression, African-Americans reported lower rates of physician-diagnosed depression than Whites, OR = 0.470. In logistic regression, those African Americans who endorsed depression diagnosis reported marginally lower rates of pharmacotherapy than Whites, OR = 0.415. Conclusions: Providers are encouraged to address depression in their diabetic patients, paying particular attention to minorities.

KW - Depression

KW - Diabetes

KW - Disparities

KW - Ethnicity

KW - Race

UR - http://www.scopus.com/inward/record.url?scp=33845199323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845199323&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2006.05.004

DO - 10.1016/j.diabres.2006.05.004

M3 - Article

VL - 75

SP - 119

EP - 122

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 1

ER -